Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. As a company whose business goals fully align with its members' health needs, Clover works with members and their doctors to become a valued partner. This trust is built by proactively identifying at-risk individuals and teaming up with physicians to accelerate care coordination and simultaneously improve health outcomes and reduce avoidable costs. Clover has offices in San Francisco, Jersey City, Nashville and Hong Kong.
Company profile
Ticker
CLOV
Exchange
Website
CEO
Vivek Garipalli
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Social Capital Hedosophia Holdings Corp. III
SEC CIK
Corporate docs
Subsidiaries
Clover Health Labs, LLC • Clover Health International, Corp. • Clover Health Corp. • Clover Health Holdings, Inc. • Clover Health Partners, LLC • Clover HMO Corp. • Principium Health, LLC • Clover Health HK Limited • Clover Healthcare, LLC • Clover Health, LLC ...
IRS number
981515192
CLOV stock data
Analyst ratings and price targets
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
17 Mar 23
S-8
Registration of securities for employees
9 Mar 23
10-K
2022 FY
Annual report
1 Mar 23
8-K
Clover Health Reports Fourth Quarter and Full Year 2022 Financial Results
28 Feb 23
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
2 Feb 23
8-K
Departure of Directors or Certain Officers
20 Jan 23
8-K
Departure of Directors or Certain Officers
10 Jan 23
UPLOAD
Letter from SEC
15 Dec 22
8-K
Dr. Anna Loengard Joins Clover Health Board of Directors
30 Nov 22
CORRESP
Correspondence with SEC
22 Nov 22
Transcripts
CLOV
Earnings call transcript
2022 Q4
28 Feb 23
CLOV
Earnings call transcript
2022 Q3
7 Nov 22
CLOV
Earnings call transcript
2022 Q2
9 Aug 22
CLOV
Earnings call transcript
2022 Q1
10 May 22
CLOV
Earnings call transcript
2021 Q4
24 Feb 22
CLOV
Earnings call transcript
2021 Q3
9 Nov 21
CLOV
Earnings call transcript
2021 Q2
12 Aug 21
CLOV
Earnings call transcript
2021 Q1
17 May 21
CLOV
Earnings call transcript
2020 Q4
2 Mar 21
Latest ownership filings
SC 13G/A
VANGUARD GROUP INC
9 Feb 23
SC 13G
BlackRock Inc.
3 Feb 23
4
Anna U Loengard
5 Jan 23
4
William G Robinson Jr
5 Jan 23
4
LEE SHAPIRO
5 Jan 23
4
Demetrios L. Kouzoukas
5 Jan 23
4
Carladenise Armbrister Edwards
5 Jan 23
4
Chelsea Clinton
5 Jan 23
4
Jamie L. Reynoso
5 Jan 23
3/A
Anna U Loengard
5 Jan 23
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 186.21 mm | 186.21 mm | 186.21 mm | 186.21 mm | 186.21 mm | 186.21 mm |
| Cash burn (monthly) | 65.55 mm | 9.48 mm | 35.72 mm | 30.91 mm | 69.79 mm | 16.99 mm |
| Cash used (since last report) | 177.44 mm | 25.66 mm | 96.69 mm | 83.67 mm | 188.91 mm | 46.00 mm |
| Cash remaining | 8.77 mm | 160.55 mm | 89.52 mm | 102.54 mm | -2.70 mm | 140.21 mm |
| Runway (months of cash) | 0.1 | 16.9 | 2.5 | 3.3 | -0.0 | 8.3 |
Institutional ownership, Q2 2022
7.1% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 2 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 5.50 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Integrated Core Strategies | 5.40 mm | $0.00 |
| Linden Capital | 100.47 k | $0.00 |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Jan 23 | Jamie L. Reynoso | Class A Common Stock | Grant | Acquire A | No | No | 0 | 353,982 | 0.00 | 1,454,877 |
| 3 Jan 23 | Clinton Chelsea | Class A Common Stock | Grant | Acquire A | No | No | 0 | 176,991 | 0.00 | 335,654 |
| 3 Jan 23 | Carladenise Armbrister Edwards | Class A Common Stock | Grant | Acquire A | No | No | 0 | 176,991 | 0.00 | 206,067 |
| 3 Jan 23 | Demetrios L. Kouzoukas | Class A Common Stock | Grant | Acquire A | No | No | 0 | 176,991 | 0.00 | 222,870 |
| 3 Jan 23 | Shapiro Lee | Class A Common Stock | Grant | Acquire A | No | No | 0 | 176,991 | 0.00 | 331,462 |
News
Canaccord Genuity Maintains Buy on Clover Health Investments, Lowers Price Target to $3
6 Mar 23
Credit Suisse Maintains Underperform on Clover Health Investments, Lowers Price Target to $1.25
6 Mar 23
Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
28 Feb 23
Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday
28 Feb 23
Why Clover Health Stock Is Rising Today
28 Feb 23
Press releases
Clover Health to Present at Barclays 2023 Global Healthcare Conference on March 14, 2023
7 Mar 23
Thinking about buying stock in AMC Entertainment, Cardio Diagnostics, Lucira Health, Meta Platforms, or Clover Health?
28 Feb 23
Clover Health Reports Fourth Quarter and Full Year 2022 Financial Results
28 Feb 23
Clover Health to Present at Citi's 2023 Healthcare Conference on March 1, 2023
22 Feb 23
Clover Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
30 Jan 23